INSUBCONTINENT EXCLUSIVE:
Shares of Shilpa Medicare rallied over 11 per cent in early trade on Wednesday on getting EIR from USFDA for facilities located in
Karnataka.
The company informed bourses that it has received establishment inspection report (EIR) from the US health regulator for both API
manufacturing facilities located at Raichur, Karnataka.
The scrip was trading 11.47 per cent up at Rs 427.50 at around 9.40 am (IST), while
Report) from USFDA to both our API manufacturing facilities located at Raichur, Karnataka
This inspection was carried out between 16th and 19th January 2018
that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.
The stock is trading
higher than 5 and 20-day moving average (DMA) but lower than its 50-DMA, 100 as well as 200-day moving average.
